Ifosfamide, epirubicin and cisplatin (IEP): another active combination for small cell lung cancer (SCLC)

Sixty-four SCLC patients (44 males and 20 females, median age 60 years, median PS 60%) were treated with an IEP regimen. Forty-nine cases were evaluable, 35 cases were limited disease (LD) and 14 cases were extensive disease (ED). Treatment consisted of ifosfamide 1.5 g/m2 i.v. infusion for 4 h on d...

Full description

Saved in:
Bibliographic Details
Main Authors: Thongprasert S., Jiamsriponges K.
Format: Article
Language:English
Published: 2014
Online Access:http://www.ncbi.nlm.nih.gov/pubmed/3502482
http://cmuir.cmu.ac.th/handle/6653943832/3518
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English